Investigation of immune pathways and genetics underlying resistance and tolerance in severe infection

Grant number: 222894/Z/21/Z

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2023
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Fergus Hamilton
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Bristol
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Infection is very common, but rarely deadly. For my PhD I want to explore the balance between 'resistance' to infection - the ability to kill and destroy invading pathogens like bacteria, fungi and viruses, with 'tolerance' to infection - the ability to bear an infection without adverse effects when these pathogens attack. Both these strategies are governed by immune pathways and are critical to survival from infection. I will focus on whether we can use large human studies, model or in vitro work about the activity of genes when we do get infected and attempt to identify specific pathways that are a 'trade-off' between these two evolutionary strategies - tolerance and resistance . I will target my investigation on the haem degradation pathway, which controls iron transport and storage. Iron is a critical nutrient for both hosts and pathogens, and has been shown to be important in determining infection outcomes. I will explore how this pathway is regulated in large datasets from sepsis and COVID-19 patients. I will also explore the balance between incidence and case fatality of infection using large genetic datasets, to explore whether genes that make you resist infection are more likely to make you die.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

Non-linear Mendelian randomization: evaluation of effect modification in the residual and doubly-ranked methods with simulated and empirical examples.

Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023.

Non-linear Mendelian randomization: detection of biases using negative controls with a focus on BMI, Vitamin D and LDL cholesterol.

Response to "Importance of method assumptions".

Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023

A quantitative evaluation of aerosol generation during cardiopulmonary resuscitation.

Challenges in undertaking nonlinear Mendelian randomization.

Low levels of small HDL particles predict but do not influence risk of sepsis.

The Natural History of Antibiotic-Treated Lower Limb Cellulitis: Analysis of Data Extracted From a Multicenter Clinical Trial.